RELMADA THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementRelmada Therapeutics, Inc. • October 2nd, 2015 • Pharmaceutical preparations • New York
Company FiledOctober 2nd, 2015 Industry JurisdictionRelmada Therapeutics, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: